Synopsis
Synopsis
0
KDMF
0
VMF
0
Australia
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 4-amino-5-chloro-n-(2-(diethylamino)ethyl)-2-methoxybenzamide
2. Cerucal
3. Dihydrochloride, Metoclopramide
4. Hydrochloride, Metoclopramide
5. Maxolon
6. Metaclopramide
7. Metoclopramide
8. Metoclopramide Dihydrochloride
9. Metoclopramide Monohydrochloride
10. Metoclopramide Monohydrochloride, Monohydrate
11. Monohydrochloride, Metoclopramide
12. Primperan
13. Reglan
14. Rimetin
1. 7232-21-5
2. Maxolon
3. Metoclopramide Hcl
4. Metoclopramide Monohydrochloride
5. Cerucal
6. Paspertin
7. Clopra
8. Reglan
9. 4-amino-5-chloro-n-(2-(diethylamino)ethyl)-2-methoxybenzamide Hydrochloride
10. Metozolv
11. Metozolv Odt
12. Metoclopramide Hydrochloride Anhydrous
13. 7b1qzy5swz
14. Metoclopramide (hydrochloride)
15. Mls000069667
16. 4-amino-5-chloro-n-[2-(diethylamino)ethyl]-2-methoxybenzamide;hydrochloride
17. Benzamide, 4-amino-5-chloro-n-(2-(diethylamino)ethyl)-2-methoxy-, Monohydrochloride
18. Nsc-354467
19. Rimetin
20. Smr000058471
21. 4-amino-5-chloro-n-(2-(diethylamino)ethyl)-o-anisamide Hydrochloride
22. Primperan (tablet)
23. Metoclopramide Hydrochloride 100 Microg/ml In Acetonitrile
24. Metoclopramide Intensol
25. Reglan Odt
26. Ccris 7142
27. Sr-01000000165
28. Einecs 230-634-5
29. Unii-7b1qzy5swz
30. Nsc 354467
31. 4-amino-5-chloro-n-[2-(diethylamino)ethyl]-o-anisamide Hydrochloride
32. Prestwick_332
33. 4-amino-5-chloro-n-(2-diethylaminoethyl)-2-methoxy-benzamide
34. Mfcd00058011
35. Metoclopramidehcl
36. Opera_id_1671
37. Mls001074186
38. Mls002222202
39. O-anisamide, Monohydrochloride
40. Schembl205200
41. Spectrum1500410
42. Chembl1256771
43. Dtxsid10964306
44. Hms1568j19
45. Hms1920n15
46. Metoclopramide Hydrochloride, Solid
47. Pharmakon1600-01500410
48. Bcp28471
49. Tox21_500762
50. Nsc354467
51. Nsc757117
52. 4-amino-5-chloro-n-(2-diethylaminoethyl)-2-methoxybenzamide Hydrochloride
53. Akos015889947
54. O-anisamide, 4-amino-5-chloro-n-(2-(diethylamino)ethyl)-, Monohydrochloride
55. Ccg-212697
56. Hs-0006
57. Lp00762
58. Nc00519
59. 4-amino-5-chloro-n-(2-(diethylamino)ethyl)-2-methoxybenzamide Monohydrochloride
60. Ncgc00094102-01
61. Ncgc00094102-02
62. Ncgc00094102-03
63. Ncgc00094102-04
64. Ncgc00094102-05
65. Ncgc00261447-01
66. Wln: 2n2&2mvr Dz Cg Fo1 &gh
67. Eu-0100762
68. Ft-0657870
69. Ft-0672375
70. S4289
71. Sw196611-3
72. Vu0239518-5
73. A14247
74. M 0763
75. A923754
76. Sr-01000000165-2
77. Sr-01000000165-7
78. Q27267998
79. 4-amino-5-chloro-n-(2-diethylaminoethyl)-2-methoxybenzamide Hcl
80. 4-amino-5-chloro-n-(2-(diethylamino)ethyl)-o-anisamidmonohydrochloride
81. 4-amino-5-chloro-n-(2-(diethylamino)ethyl)-o-anisamide Monohydrochloride
82. Benzamide, 4-amino-5-chloro-n-(2-(diethylamino)ethyl)-2-methoxy-, Monohydrochloride (9ci)
83. Benzamide, 4-amino-5-chloro-n-[2-(diethylamino)ethyl]-2-methoxy-, Hydrochloride (1:1)
Molecular Weight | 336.3 g/mol |
---|---|
Molecular Formula | C14H23Cl2N3O2 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 7 |
Exact Mass | 335.1167324 g/mol |
Monoisotopic Mass | 335.1167324 g/mol |
Topological Polar Surface Area | 67.6 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 300 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Metoclopramide hydrochloride |
Drug Label | Metoclopramide hydrochloride is a white or practically white, crystalline, odorless or practically odorless powder. It is very soluble in water, freely soluble in alcohol, sparingly soluble in chloroform, practically insoluble in ether. Chemically it... |
Active Ingredient | Metoclopramide hydrochloride |
Dosage Form | Tablet; Injectable; Tablet, orally disintegrating; Solution |
Route | Injection; Oral |
Strength | eq 5mg base; eq 5mg base/5ml; eq 5mg base/ml; eq 10mg base |
Market Status | Prescription |
Company | Vintage Pharms; Wockhardt; Silarx; Ani Pharms; Hospira; Teva; Pharm Assoc; Teva Pharms Usa; Northstar Hlthcare; Par Pharm; Novel Labs; Watson Labs; Vistapharm; Ipca Labs; Mutual Pharm; Bd Rx |
2 of 4 | |
---|---|
Drug Name | Metozolv odt |
PubMed Health | Metoclopramide |
Drug Classes | Antiemetic, Diagnostic Agent, Stimulant, Gastrointestinal |
Drug Label | METOZOLV ODT is an orally disintegrating tablet formulation of metoclopramide hydrochloride. The 5 mg strength is a round white tablet debossed on one side with a 5 and plain on the other side; it is comprised of 5 mg metoclopramide (as 5.91... |
Active Ingredient | Metoclopramide hydrochloride |
Dosage Form | Tablet, orally disintegrating |
Route | Oral |
Strength | eq 5mg base |
Market Status | Prescription |
Company | Salix Pharms |
3 of 4 | |
---|---|
Drug Name | Metoclopramide hydrochloride |
Drug Label | Metoclopramide hydrochloride is a white or practically white, crystalline, odorless or practically odorless powder. It is very soluble in water, freely soluble in alcohol, sparingly soluble in chloroform, practically insoluble in ether. Chemically it... |
Active Ingredient | Metoclopramide hydrochloride |
Dosage Form | Tablet; Injectable; Tablet, orally disintegrating; Solution |
Route | Injection; Oral |
Strength | eq 5mg base; eq 5mg base/5ml; eq 5mg base/ml; eq 10mg base |
Market Status | Prescription |
Company | Vintage Pharms; Wockhardt; Silarx; Ani Pharms; Hospira; Teva; Pharm Assoc; Teva Pharms Usa; Northstar Hlthcare; Par Pharm; Novel Labs; Watson Labs; Vistapharm; Ipca Labs; Mutual Pharm; Bd Rx |
4 of 4 | |
---|---|
Drug Name | Metozolv odt |
PubMed Health | Metoclopramide |
Drug Classes | Antiemetic, Diagnostic Agent, Stimulant, Gastrointestinal |
Drug Label | METOZOLV ODT is an orally disintegrating tablet formulation of metoclopramide hydrochloride. The 5 mg strength is a round white tablet debossed on one side with a 5 and plain on the other side; it is comprised of 5 mg metoclopramide (as 5.91... |
Active Ingredient | Metoclopramide hydrochloride |
Dosage Form | Tablet, orally disintegrating |
Route | Oral |
Strength | eq 5mg base |
Market Status | Prescription |
Company | Salix Pharms |
Dopamine D2 Receptor Antagonists
Compounds and drugs that bind to and inhibit or block the activation of DOPAMINE D2 RECEPTORS. (See all compounds classified as Dopamine D2 Receptor Antagonists.)
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
35
PharmaCompass offers a list of Metoclopramide Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Metoclopramide Hydrochloride manufacturer or Metoclopramide Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Metoclopramide Hydrochloride manufacturer or Metoclopramide Hydrochloride supplier.
PharmaCompass also assists you with knowing the Metoclopramide Hydrochloride API Price utilized in the formulation of products. Metoclopramide Hydrochloride API Price is not always fixed or binding as the Metoclopramide Hydrochloride Price is obtained through a variety of data sources. The Metoclopramide Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Metoclopramide Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Metoclopramide Hydrochloride, including repackagers and relabelers. The FDA regulates Metoclopramide Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Metoclopramide Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Metoclopramide Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Metoclopramide Hydrochloride supplier is an individual or a company that provides Metoclopramide Hydrochloride active pharmaceutical ingredient (API) or Metoclopramide Hydrochloride finished formulations upon request. The Metoclopramide Hydrochloride suppliers may include Metoclopramide Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Metoclopramide Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Metoclopramide Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Metoclopramide Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Metoclopramide Hydrochloride DMFs exist exist since differing nations have different regulations, such as Metoclopramide Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Metoclopramide Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Metoclopramide Hydrochloride USDMF includes data on Metoclopramide Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Metoclopramide Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Metoclopramide Hydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Metoclopramide Hydrochloride Drug Master File in Japan (Metoclopramide Hydrochloride JDMF) empowers Metoclopramide Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Metoclopramide Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Metoclopramide Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Metoclopramide Hydrochloride suppliers with JDMF on PharmaCompass.
A Metoclopramide Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Metoclopramide Hydrochloride Certificate of Suitability (COS). The purpose of a Metoclopramide Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Metoclopramide Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Metoclopramide Hydrochloride to their clients by showing that a Metoclopramide Hydrochloride CEP has been issued for it. The manufacturer submits a Metoclopramide Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Metoclopramide Hydrochloride CEP holder for the record. Additionally, the data presented in the Metoclopramide Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Metoclopramide Hydrochloride DMF.
A Metoclopramide Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Metoclopramide Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Metoclopramide Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Metoclopramide Hydrochloride written confirmation (Metoclopramide Hydrochloride WC) is an official document issued by a regulatory agency to a Metoclopramide Hydrochloride manufacturer, verifying that the manufacturing facility of a Metoclopramide Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Metoclopramide Hydrochloride APIs or Metoclopramide Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Metoclopramide Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Metoclopramide Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Metoclopramide Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Metoclopramide Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Metoclopramide Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Metoclopramide Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Metoclopramide Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Metoclopramide Hydrochloride suppliers with NDC on PharmaCompass.
Metoclopramide Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Metoclopramide Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Metoclopramide Hydrochloride GMP manufacturer or Metoclopramide Hydrochloride GMP API supplier for your needs.
A Metoclopramide Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Metoclopramide Hydrochloride's compliance with Metoclopramide Hydrochloride specifications and serves as a tool for batch-level quality control.
Metoclopramide Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Metoclopramide Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Metoclopramide Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Metoclopramide Hydrochloride EP), Metoclopramide Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Metoclopramide Hydrochloride USP).